PB vs Industry: BEEM is overvalued based on its PB Ratio (7.1x) compared to the US Electrical industry average (3x).
Then Will Beem stock go up? Stock Price Forecast
The 4 analysts offering 12-month price forecasts for Beam Global have a median target of 45.50, with a high estimate of 50.00 and a low estimate of 37.00. The median estimate represents a +108.33% increase from the last price of 21.84.
Furthermore, Is BNGO a good buy?
With Progress on Multiple Fronts, Bionano Genomics Stock Is Great Buy Here. Bionano Genomics (NASDAQ:BNGO) continues to take steps that will, in the long-term, tremendously boost its results and the share price. Consequently, I remain very bullish on BNGO stock.
Is BNGO a pump and dump? BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.
Table of Contents
Does Ark hold BNGO?
More than three months of persistent stock promotion along the lines of “today is finally the day!” ARK Genomic Revolution ETF (NYSEARCA:ARKG) will show more than just mouthpiece interest, BNGO remains a goose egg for the fund through the end of the first quarter.
Will BNGO get FDA approval?
The Food and Drug Administration has not yet approved the device for use as a medical diagnostic tool in the U.S. However, healthcare entities can still use it for research purposes. The lack of FDA approval has also not hindered sales of the Saphyr in other countries.
Is BNGO expected to rise?
Bionano Genomics Inc (NASDAQ:BNGO)
The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 12.00, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +260.36% increase from the last price of 3.33.
Is BNGO being shorted?
0.00% of Bionano Genomics’ shares are currently sold short.
Who is buying BNGO?
Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares bought / sold |
|---|---|---|
| The Vanguard Group, Inc. | 5.11% | +208,538 |
| SSgA Funds Management, Inc. | 2.70% | +6,753 |
| Geode Capital Management LLC | 1.67% | -19,559 |
| Bank Julius B r & Co. AG | 1.43% | +1,283,418 |
What ETFS have BNGO?
(BNGO) exposure | ETF.com.
…
ETFs with the most BNGO shares.
| Ticker | Fund Name | # OF SHARES |
|---|---|---|
| IWM | iShares Russell 2000 ETF | 6.32M |
| IWO | iShares Russell 2000 Growth ETF | 2.24M |
| KOMP | SPDR S&P Kensho New Economies Composite ETF | 2.05M |
| VTI | Vanguard Total Stock Market ETF | 1.57M |
Is BNGO in ETF?
develops and markets the Saphyr system, a platform for structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics.
…
| ETF | BNGO |
|---|---|
| EPS | -0.39 |
Is BNGO a buy or sell?
For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment.
…
Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 25.42% |
| 2 | Buy | 19.05% |
| 3 | Hold | 10.68% |
| 4 | Sell | 6.41% |
Is Bionano genomics profitable?
Bionano Genomics wasn’t profitable in the last twelve months, it is unlikely we’ll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. When a company doesn’t make profits, we’d generally expect to see good revenue growth.
Is BNGO undervalued?
Bionano Genomics (NASDAQ:BNGO) stock, along with most other meme stocks, has been tumbling in recent weeks. But unlike most other meme names, Bionano has a highly disruptive product, and its shares are tremendously undervalued.
What is the float on BNGO?
Share Statistics
| Avg Vol (3 month) 3 | 8.4M |
|---|---|
| Float 8 | 280.78M |
| % Held by Insiders 1 | 2.17% |
| % Held by Institutions 1 | 25.31% |
| Shares Short (Nov 15, 2021) 4 | 37.5M |
What is BNGO target price?
Stock Price Targets
| High | $14.00 |
|---|---|
| Median | $12.00 |
| Low | $10.00 |
| Average | $12.00 |
| Current Price | $3.4000 |
What is a stock squeeze?
The term “squeeze” is used to describe many financial and business situations, typically involving some sort of market pressure. … In the financial world, the term is used to describe situations wherein short-sellers purchase stock to cover losses or when investors sell long positions to take capital gains off the table.
Does Ark invest BNGO stock?
Ark Invest’s Chapter in the BNGO Stock Story
The fund manager has sent some public praise BNGO’s way. Ark even has a special portfolio — Ark Genomic Revolution ETF (NYSEARCA:ARKG) — for just that sort of stock material.
Does Vanguard own BNGO stock?
Common Stock (BNGO) Institutional Holdings | Nasdaq.
…
New and Sold Out Positions.
| OWNER NAME | VANGUARD GROUP INC |
|---|---|
| DATE | 09/30/2021 |
| SHARES HELD | 15,053,272 |
| CHANGE (SHARES) | 197,836 |
| CHANGE (%) | 1.332% |
What institutions are buying NIO?
NIO (NYSE NIO) Institutional Buying and Selling
American International Group Inc. Migdal Insurance & Financial Holdings Ltd. Global Wealth Management Investment Advisory Inc. National Asset Management Inc.
Who is holding BNGO stock?
Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 5.11% | 14,266,959 |
| SSgA Funds Management, Inc. | 2.70% | 7,522,852 |
| Geode Capital Management LLC | 1.67% | 4,672,052 |
| Bank Julius B r & Co. AG | 1.43% | 3,991,194 |
Is Bionano a meme stock?
Admittedly, it has been a while since Bionano Genomics (NASDAQ:BNGO) stock has been a “hot stock,” a “meme stock” or whatever you want to call it. … That’s why, as a result of a spate of positive developments, shares skyrocketed in value around the start of 2021.
How many patents does BNGO have?
“The patent issued today provides further protection of methods to characterize single DNA molecules and strengthens Bionano’s global patent portfolio that includes 67 issued patents across 14 patent families and numerous patent applications.
How much cash does BNGO have?
Compare BNGO With Other Stocks
| Bionano Genomics Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2020 | $38 |
| 2019 | $17 |
| 2018 | $17 |
| 2017 | $1 |
